CME Cme Group Inc
Price (delayed)
$248.87
Market cap
$89.68B
P/E Ratio
26.11
Dividend/share
$10.4
EPS
$9.53
Enterprise value
$190.25B
CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals,
Highlights
The company's net income rose by 14% YoY and by 4.9% QoQ
The EPS is up by 14% year-on-year and by 5% since the previous quarter
CME's P/E is 12% above its last 4 quarters average of 23.3 but 3.3% below its 5-year quarterly average of 27.0
The debt has grown by 15% since the previous quarter and by 14% year-on-year
Key stats
What are the main financial stats of CME
Market
Valuations
Earnings
Shares outstanding
360.36M
Market cap
$89.68B
Enterprise value
$190.25B
Price to earnings (P/E)
26.11
Price to book (P/B)
3.18
Price to sales (P/S)
14.8
EV/EBIT
41.29
EV/EBITDA
38.45
EV/Sales
31.48
Revenue
$6.04B
Gross profit
$6.04B
Operating income
$3.85B
Net income
$3.46B
EBIT
$4.61B
EBITDA
$4.95B
Free cash flow
$3.63B
Per share
Balance sheet
Liquidity
EPS
$9.53
EPS diluted
$9.51
Free cash flow per share
$10.1
Book value per share
$78.36
Revenue per share
$16.82
TBVPS
$298.31
Total assets
$137.8B
Total liabilities
$109.58B
Debt
$102.88B
Equity
$28.22B
Working capital
$2.32B
Debt to equity
3.65
Current ratio
1.02
Quick ratio
1.02
Net debt/EBITDA
20.33
Margins
Efficiency
Dividend
EBITDA margin
81.9%
Gross margin
100%
Net margin
57.3%
Operating margin
63.7%
Return on assets
2.6%
Return on equity
12.5%
Return on invested capital
4.6%
Return on capital employed
12.5%
Return on sales
76.2%
Dividend yield
4.18%
DPS
$10.4
Payout ratio
109.1%
CME stock price
How has the Cme Group stock price performed over time
Intraday
0.22%
1 week
1.38%
1 month
7.16%
1 year
15.75%
YTD
7.17%
QTD
7.17%
Financial performance
How have Cme Group's revenue and profit performed over time
Revenue
$6.04B
Gross profit
$6.04B
Operating income
$3.85B
Net income
$3.46B
Gross margin
100%
Net margin
57.3%
The operating income is up by 19% YoY and by 6% QoQ
The company's net income rose by 14% YoY and by 4.9% QoQ
The gross profit has increased by 13% YoY and by 4.3% from the previous quarter
CME's revenue is up by 13% year-on-year and by 4.3% since the previous quarter
Growth
What is Cme Group's growth rate over time
Valuation
What is Cme Group stock price valuation
P/E
26.11
P/B
3.18
P/S
14.8
EV/EBIT
41.29
EV/EBITDA
38.45
EV/Sales
31.48
The EPS is up by 14% year-on-year and by 5% since the previous quarter
CME's P/E is 12% above its last 4 quarters average of 23.3 but 3.3% below its 5-year quarterly average of 27.0
CME's price to book (P/B) is 22% higher than its 5-year quarterly average of 2.6 and 14% higher than its last 4 quarters average of 2.8
The equity has grown by 2.1% since the previous quarter
CME's revenue is up by 13% year-on-year and by 4.3% since the previous quarter
The P/S is 12% higher than the last 4 quarters average of 13.2 and 6% higher than the 5-year quarterly average of 13.9
Efficiency
How efficient is Cme Group business performance
The ROIC has grown by 39% YoY
Cme Group's return on assets has increased by 30% YoY
Cme Group's return on equity has increased by 15% YoY and by 5% QoQ
Dividends
What is CME's dividend history
DPS
$10.4
Dividend yield
4.18%
Payout ratio
109.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cme Group financials performed over time
Cme Group's total assets is 26% more than its total liabilities
Cme Group's total liabilities has increased by 14% QoQ and by 12% YoY
Cme Group's total assets has increased by 12% from the previous quarter and by 10% YoY
The debt has grown by 15% since the previous quarter and by 14% year-on-year
The debt to equity has grown by 13% from the previous quarter and by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.